Cargando…
Prognostic Value of Metabolic Syndrome in Patients With Non-ST Elevated Myocardial Infarction Undergoing Percutaneous Coronary Intervention
OBJECTIVE: We aim to investigate the prognostic effects of metabolic syndrome (MS) on patients with non-ST elevated myocardial infarction (NSTEMI) after percutaneous coronary intervention (PCI). METHODS: Patients with NSTEMI undergoing PCI were consecutively collected. According to the presence or a...
Autores principales: | Zhao, Li-Hong, Liu, Yin, Xiao, Jian-Yong, Wang, Ji-Xiang, Li, Xiao-Wei, Cui, Zhuang, Gao, Jing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9260082/ https://www.ncbi.nlm.nih.gov/pubmed/35811732 http://dx.doi.org/10.3389/fcvm.2022.912999 |
Ejemplares similares
-
Prognostic Value of Total Bilirubin in Patients With ST-Segment Elevation Acute Myocardial Infarction Undergoing Primary Coronary Intervention
por: Zhao, Xiaoxiao, et al.
Publicado: (2020) -
Long-term prognostic value of macrophage migration inhibitory factor in ST-segment elevation myocardial infarction patients with metabolic syndrome after percutaneous coronary intervention
por: Yu, Xiao-Lin, et al.
Publicado: (2022) -
Validation and Comparison of Six Risk Scores for Infection in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention
por: Liu, Yuanhui, et al.
Publicado: (2021) -
Clinical Impact of Thrombus Aspiration and Interaction With D-Dimer Levels in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
por: Li, Jun-feng, et al.
Publicado: (2021) -
Predicting value of white cell count and total bilirubin on clinical outcomes in patients with ST-elevation myocardial infarction following percutaneous coronary intervention: a cohort study
por: Tuxun, Munire, et al.
Publicado: (2020)